Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC4711 (Rucosopasem) + SBRT in Pancreatic Cancer
NCT04698915Phase 2Terminated
- Sponsor
- Galera Therapeutics, Inc.
- Start
- May 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of rucosopasem manganese in pancreatic cancer (PC), sponsored by Galera Therapeutics, Inc.. Started May 2021; status: terminated.
02
Drugs
rucosopasem manganese
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04698915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04698915.